Skin tags and atherosclerotic risk factors

Journal of Dermatology

Volumn 32, Issue 5, 2005, Pages 371-375

  Erdoǧan, Berna Şanli ^a,c   Aktan, Şebnem ^b   Rota, Simin ^a   Ergin, Şeniz ^a   Evliyaoǧlu, Deniz ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Dyslipidemia; Insulin resistance; Skin tags

Indexed keywords

CARBOHYDRATE; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; BENIGN TUMOR; BODY MASS; CARBOHYDRATE METABOLISM; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOASSAY; INSULIN RESISTANCE; LIPID METABOLISM; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; RISK FACTOR; SKIN TAG;

EID: 21044432906     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2005.tb00909.x     Document Type: Article

References (19)

1. Mathur SK, Bharvaga P: Insulin resistance and skin tags, Dermatology, 195: 184, 1997.
2. Demir S, Demir Y: Acrochordon and impaired carbohydrate metabolism, Acta Diabetol, 39: 57-59, 2002.
3. Crook MA: Skin tags and atherogenic lipid profile, J Clin Pathol, 53: 873-874, 2000.
4. Norris PG, McFadden J, Gale E, Griffiths WAD: Skin tags are more closely related to fasting insulin than fasting glucose levels, Acta Derm Venereal (Stockh), 68: 367-368, 1988.
5. Agarwal JK, Nigam PK: Acrochordon: A cutaneous sign of carbohydrate intolerance, Australas J Dermatol, 28: 132-133, 1987.
6. Khana M, Grossman E, Feinstein A, Ronnen M, Cohen M, Millet MS: Skin tags: A cutaneous marker for diabetes mellitus, Acta Derm Venereol (Stockh), 67: 175-177, 1987.
7. Margolis J, Margolis LS: Skin tags -A frequent sign of diabetes mellitus, N Eng J Med, 20: 1184, 1976.
8. Hostetter AL: Screening for dyslipidemia. Practice parameter, Am J Clin Pathol, 103: 380-385, 1995.
9. Kong C, Elatrozy T, Anyaoku V, Robinson S, Richmond W, Elkeles RS: Insulin resistance, cardiovascular risk factors and ultrasonically measured early arterial disease in normotensive type 2 diabetic subjects, Diabetes Metab Res Rev, 16: 448-453, 2000.
10. Hsueh WA, Law RE: Cardiovascular risk continuum: Implications of insulin resistance and diabetes, Am J Med, 105: 4s-14s, 1998.
11. Wallace TM, Matthews DR: The assessment of insulin resistance in man, Diabet Med, 19: 527-534, 2002.
12. Marques-Vidal P, Mazoyer E, Bongard V, et al: Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers, Diabetes Care, 25: 1371-1377, 2002.
13. American Diabetes Association: Screening for type 2 diabetes, Diabetes Care, 27: 11s-14s, 2004.
14. Gregg EW, Gerzoff RB, Thompson TJ, Williamson DF: Trying to lose weight, losing weight, and 9-year mortality in overweight U.S adults with diabetes, Diabetes Care, 27: 657-662, 2004.
15. Dianzani C, Calvieri S, Pierangeli A, Imperi M, Bucci M, Degener AM: The detection of human papilloma virus DNA in skin tags, Br J Dermatol, 138: 649-651, 1998.
16. Braun Falco O, Plewig G, Wolff HH, Burgdorf WHC: Dermatology, ed 2, Springer-Verlag, Berlin, 2000.
17. Nanney LB, Ellis DL, Levine J, King LE: Epidermal growth factor receptors in idiopathic and virally induced skin disease, Am J Pathol, 140: 915-925, 1992.
18. Cordain L, Eades MR, Eades MD: Hyperinsulinemic disease of civilization: More than just Syndrome X, Comp Biochem Physiol A Mol Integr Physiol Part A, 136: 95-112, 2003.
19. Lerman I, Villa AR, Torres JMR, et al: Correlations between surrogate measures of insulin resistance and cardiovascular risk factors in obese and overweight patients, J Diabetes Complications, 17: 66-72, 2003.